Research Insight
Gilead’s Harvoni receives FDA approval for hepatitis C genotype 1 infection
Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir 90mg/sofosbuvir 400mg), a once-daily single tablet regimen to treat...
Research Insight
EMD Serono, ICR and Wellcome Trust partner develop anti-cancer drugs
Merck subsidiary EMD Serono, The Institute of Cancer Research (ICR) and the Wellcome Trust have entered into a co-development and licence agreement for...
Research Insight
Novartis and BMS enter clinical collaboration to assess lung cancer treatments
Swiss drug maker Novartis has partnered with US-based Bristol-Myers Squibb (BMS) to assess the safety, tolerability and preliminary efficacy of its three molecularly...
Research Insight
UK’s Medical Research Council grants fund for three new research programmes
The UK Medical Research Council (MRC) has granted a fund of £6m for three new research programmes, as part of a £60m investment. The ...
Research Insight
Afatinib drug could inhibit growth of womb cancer, say Yale scientists
Research conducted by scientists from the Yale School of Medicine gynaecologic oncology division has demonstrated that the drug afatinib could inhibit the...
Research Insight
PANEL: FLU SPRAY BETTER THAN SHOTS FOR YOUNG KIDS
When it comes to flu vaccines, a federal panel says a squirt in the nose is better than a shot in the arm for young...
Research Insight
Reducing readmissions: Top strategy for improving quality, lowering costs
Dr. Fortuna says payers should consider expand their perspectives on improving the healthcare system by adopting the use of the tools, methodologies and quality improvement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.